TX HHS Form 1354. PCSK9 Inhibitors Authorization Request (Medicaid Fee-for-Service)
The PCSK9 Inhibitors Authorization Request Form (TX HHS Form 1354) is a crucial document for healthcare providers in Texas. This form helps solve the problem of obtaining authorization for patients to receive PCSK9 inhibitors, which are FDA-approved medications used to treat high cholesterol.
TX HHS Form 1353. Texas Medicaid OxyContin Prior Authorization Request
The Texas Medicaid OxyContin Prior Authorization Request Form 1353 helps healthcare providers obtain approval for patients' prescriptions of OxyContin.
TX HHS Form 1351. Request to Withdraw from the CLASS Application Process
The TX HHS Form 1351, Request to Withdraw from the CLASS Application Process, is a practical tool for individuals who have received information about the Community Living Assistance and Support Services (CLASS) Program.
TX HHS Form 1349. Drug Utilization Review Board Annual Disclosure
The TX HHS Form 1349, Drug Utilization Review Board Annual Disclosure, is a crucial document that helps solve the problem of ensuring accurate and timely disclosures from individuals appointed to the Texas Vendor Drug Program's Drug Utilization Review Board.
TX HHS Form 1348. Texas Medicaid Phosphate Binders Prior Authorization Request
The Texas Medicaid Phosphate Binders Prior Authorization Request Form (Form 1348) is a crucial tool for healthcare providers to obtain prior authorization for phosphate binders treatment.
TX HHS Form 1347. Emflaza Prior Authorization Request
The TX HHS Form 1347, Emflaza Prior Authorization Request, is a crucial document that helps healthcare providers obtain prior authorization for the treatment of Duchenne muscular dystrophy patients with Emflaza (deflazacort).
TX HHS Form 1344. Texas Vendor Drug Program MCO Search Update Request
The Texas Vendor Drug Program MCO Search Update Request Form 1344 helps managed care organizations (MCOs) update their information in the Texas Vendor Drug Program database. This form is typically used by MCOs to modify or delete existing information related to their organization.
TX HHS Form 1342. Draft Policy Comment Submission
The TX HHS Form 1342, Draft Policy Comment Submission, is a crucial tool for stakeholders to provide feedback on proposed policies within the Vendor Drug Program (VDP).
TX HHS Form 1338. Cystic Fibrosis Treatment Agents (Kalydeco/Orkambi/Symdeko) Prior Authorization Request
The TX HHS Form 1338, Cystic Fibrosis Treatment Agents Prior Authorization Request, is a crucial document for healthcare providers to request prior authorization for patients with cystic fibrosis who require treatment agents such as Kalydeco, Orkambi, or Symdeko.
TX HHS Form 1337. CHIP Drug Rebate Agreement
The TX HHS Form 1337, CHIP Drug Rebate Agreement, is a crucial document that helps solve the problem of establishing rebates for prescription outpatient drugs utilized by Children's Health Insurance Program (CHIP) recipients.